RecruitingNot ApplicableNCT06600347

Effect of DASH Diet and Progressive Muscle Relaxation on Cardiovascular Risks in Postmenopausal Women


Sponsor

Cairo University

Enrollment

90 participants

Start Date

Jun 10, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study will be conducted to investigate the effect of DASH diet and Progressive muscle relaxation on cardiovascular risks in postmenopausal women.


Eligibility

Sex: FEMALEMin Age: 50 YearsMax Age: 60 Years

Inclusion Criteria4

  • The participant's ages will be ranged from 50- 60 years old.
  • Their body mass index will be ranged from 30-35 kg/m2.
  • All women are hypertensive at least one year postmenopause.
  • Their scores in perceived stress scale will be ranged from 14-40.

Exclusion Criteria3

  • Women with systolic blood pressure (SBP) >160 mmHg or diastolic blood pressure (DBP) >100mmHg.
  • Women who have other known causes of hypertension, such as renal diseases.
  • Women who are using sedatives or tranquilizer or antidepressant drugs.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTDASH diet

The participants will be treated with the DASH diet (1600-1800 calories/ day) for three months, in addition to antihypertensive drugs.

OTHERProgressive muscle relaxation

The participants will be treated with progressive muscle relaxation for 30 minutes, 3 times/week for 3 months, in addition to antihypertensive drugs.

DRUGAnti hypertensive drugs

All participants in all groups will be treated with antihypertensive drugs as prescribed from the physician


Locations(1)

Farahnaz Ahmed Mohamed

Suez, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06600347


Related Trials